Screener
Nuvation Bio NUVB Deferred Revenue
Deferred Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's deferred revenue?
- Nuvation Bio (NUVB) reported deferred revenue of $8.86M in Q2 2026.
- How has Nuvation Bio's deferred revenue changed year-over-year?
- Nuvation Bio's deferred revenue decreased by 8.9% year-over-year, from $9.73M to $8.86M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Nuvation Bio's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude